Literature DB >> 7988497

Distribution of lysozyme and mucin (MUC2 and MUC3) mRNA in human bronchus.

A Dohrman1, T Tsuda, E Escudier, M Cardone, B Jany, J Gum, Y Kim, C Basbaum.   

Abstract

Immunocytochemical studies have shown that gel-forming glycoproteins (mucins) and the bacteriolytic protein lysozyme are selectively expressed in airway mucous and serous cells, respectively. The mechanisms mediating this selectivity are unknown. In this study, we localized mucin and lysozyme mRNA by in situ hybridization to investigate the possibility that phenotype-specific expression of these proteins is controlled at the level of mRNA. Radiolabelled sense and antisense probes were constructed from the human tracheal mucin cDNA, HAM1 (MUC2 gene), the human small intestinal mucin cDNA, SIB139 (MUC3 gene), and the bovine tracheal lysozyme cDNA, Lys 7a. Frozen sections of human bronchus were hybridized with these probes and washed under routine conditions. Autoradiography showed that although lysozyme mRNA was strictly limited to cells expressing lysozyme, mucin mRNA was present both in mucin-expressing and mucin-non-expressing epithelial cells. This suggests that the restriction of lysozyme to serous cells is controlled at the level of mRNA (synthesis and/or degradation), whereas the restriction of mucin to mucous cells is controlled at the level of translation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988497     DOI: 10.3109/01902149409064393

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  17 in total

1.  Human bronchial epithelial cells differentiate to 3D glandular acini on basement membrane matrix.

Authors:  Xiaofang Wu; Jennifer R Peters-Hall; Sumit Bose; Maria T Peña; Mary C Rose
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

Review 2.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

3.  Use of antibodies directed against blood group substances and lectins together with glycosidase digestion to study the composition and cellular distribution of glycoproteins in the large human airways.

Authors:  R Bals; W Woeckel; U Welsch
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

4.  Respiratory mucins: identification of core proteins and glycoforms.

Authors:  D J Thornton; I Carlstedt; M Howard; P L Devine; M R Price; J K Sheehan
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 5.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

6.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

7.  Mucus glycoproteins in bovine trachea: identification of the major mucin populations in respiratory secretions and investigation of their tissue origins.

Authors:  H W Hovenberg; I Carlstedt; J R Davies
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

8.  Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease.

Authors:  J D Li; A F Dohrman; M Gallup; S Miyata; J R Gum; Y S Kim; J A Nadel; A Prince; C B Basbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

9.  Lysozyme secretion by submucosal glands protects the airway from bacterial infection.

Authors:  Rana Dajani; Yulong Zhang; Peter J Taft; Sue M Travis; Timothy D Starner; Ansgar Olsen; Joseph Zabner; Michael J Welsh; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-03       Impact factor: 6.914

Review 10.  The porcine lung as a potential model for cystic fibrosis.

Authors:  Christopher S Rogers; William M Abraham; Kim A Brogden; John F Engelhardt; John T Fisher; Paul B McCray; Geoffrey McLennan; David K Meyerholz; Eman Namati; Lynda S Ostedgaard; Randall S Prather; Juan R Sabater; David Anthony Stoltz; Joseph Zabner; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.